C. Masson (Praticien rhumatologue hospitalier), B. Bouvard (Interne), M. Audran (Professeur, chef de service)
{"title":"Manifestations rhumatologiques paranéoplasiques en dehors de l'ostéoarthropathie hypertrophiante","authors":"C. Masson (Praticien rhumatologue hospitalier), B. Bouvard (Interne), M. Audran (Professeur, chef de service)","doi":"10.1016/j.emcrho.2005.03.003","DOIUrl":null,"url":null,"abstract":"<div><p>Paraneoplastic rheumatic syndromes (PRS), as any paraneoplastic syndrome, induce signs or symptoms related to a known or an unrecognized tumour, cancer, or haemopathy, often malignant but not always. The chronologic relationship between the neoplastic process and the symptomatology is essential. PRS is not due to a tumour-induced compression or a synovial or bone peri-articular metastatic invasion. They differ from pre-neoplastic systemic rheumatic conditions. They disappear when the patient may benefit from a radical treatment. The best rheumatologic example is the hypertrophic pneumogenic osteoarthropathy described elsewhere in this work. Here we review the other PRS conditions: the palmar fasciitis syndrome; the ovary (but not exclusively) polyarthritis and cancer; the paraneoplastic muscular syndromes induced by a dermatomyositis, polymyositis, Lambert-Eaton myasthenia syndrome, and stiff man syndrome; inflammatory rheumatisms (polyarthritis, pseudo Still's disease, benign oedematous acute polyarthritis of the elderly, rhizomelic pseudoarthritis) in their rare paraneoplastic presentations; the vascular lesions (erythromelalgia, Raynaud's disease, digital necrosis, vascularitis) in their paraneoplastic presentations; other potentially paraneoplastic systemic rheumatic conditions (atrophic polychondritis, multicentric reticuloendotheliosis, panniculitis-arthritis syndrome, and amyloid arthropathy); paraneoplastic hypercalcemias, in particular those related to the parathormone-related peptide; and oncogenous osteomalacia. Clinical and paraclinical orientations are considered, according to these different situations, particularly for the presented tumoural and haematological diseases.</p></div>","PeriodicalId":100448,"journal":{"name":"EMC - Rhumatologie-Orthopédie","volume":"2 5","pages":"Pages 501-509"},"PeriodicalIF":0.0000,"publicationDate":"2005-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcrho.2005.03.003","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Rhumatologie-Orthopédie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1762420705000128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Paraneoplastic rheumatic syndromes (PRS), as any paraneoplastic syndrome, induce signs or symptoms related to a known or an unrecognized tumour, cancer, or haemopathy, often malignant but not always. The chronologic relationship between the neoplastic process and the symptomatology is essential. PRS is not due to a tumour-induced compression or a synovial or bone peri-articular metastatic invasion. They differ from pre-neoplastic systemic rheumatic conditions. They disappear when the patient may benefit from a radical treatment. The best rheumatologic example is the hypertrophic pneumogenic osteoarthropathy described elsewhere in this work. Here we review the other PRS conditions: the palmar fasciitis syndrome; the ovary (but not exclusively) polyarthritis and cancer; the paraneoplastic muscular syndromes induced by a dermatomyositis, polymyositis, Lambert-Eaton myasthenia syndrome, and stiff man syndrome; inflammatory rheumatisms (polyarthritis, pseudo Still's disease, benign oedematous acute polyarthritis of the elderly, rhizomelic pseudoarthritis) in their rare paraneoplastic presentations; the vascular lesions (erythromelalgia, Raynaud's disease, digital necrosis, vascularitis) in their paraneoplastic presentations; other potentially paraneoplastic systemic rheumatic conditions (atrophic polychondritis, multicentric reticuloendotheliosis, panniculitis-arthritis syndrome, and amyloid arthropathy); paraneoplastic hypercalcemias, in particular those related to the parathormone-related peptide; and oncogenous osteomalacia. Clinical and paraclinical orientations are considered, according to these different situations, particularly for the presented tumoural and haematological diseases.